Jump to main content
Jump to site search

Issue 43, 2016
Previous Article Next Article

Pyridine N-oxides as coformers in the development of drug cocrystals

Author affiliations

Abstract

Pyridine N-oxides were synthesized via a convenient method and exploited in the preparation of drug cocrystals. Drugs associated with aqueous solubility issues such as propofol, ferulic acid, sulfathiazole, p-aminobenzoic acid etc. were used as the representative active ingredients to engineer pharmaceutical solids of a desired phase. In this study, 4,4′-bipyridine-N,N′-dioxide was picked as the cocrystal former. The types of supramolecular heterosynthons exhibited by the binary systems of N-oxide·drugs were analyzed. The formation of hydrogen bond synthons such as COOH–pyridine N-oxide, OH or NH–pyridine N-oxide was found to be robust and followed the trend observed in the Crystal Structure Database. These synthons were further correlated with the ameliorated properties of the drugs, which was supported by experiments, DFT studies and Hirshfeld surface analysis. This has been a goal in drug development.

Graphical abstract: Pyridine N-oxides as coformers in the development of drug cocrystals

Back to tab navigation

Supplementary files

Publication details

The article was received on 22 Aug 2016, accepted on 29 Sep 2016 and first published on 29 Sep 2016


Article type: Paper
DOI: 10.1039/C6CE01838F
Citation: CrystEngComm, 2016,18, 8454-8464
  •   Request permissions

    Pyridine N-oxides as coformers in the development of drug cocrystals

    B. Saikia, R. Khatioda, P. Bora and B. Sarma, CrystEngComm, 2016, 18, 8454
    DOI: 10.1039/C6CE01838F

Search articles by author

Spotlight

Advertisements